Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a platform update reflected on the page without altering study information.
    Difference
    0.1%
    Check dated 2026-06-05T11:38:36.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new revision entry v3.5.4 to the Study Record Versions, and removed the previous revision v3.5.3 from the history. This reflects an updated revision in the study's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T05:19:19.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a new ClinicalTrials.gov revision number (from v3.5.2 to v3.5.3). This represents an interface/version update rather than a change to the trial record history itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:41:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:39.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the Record History and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:18:54.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T17:21:47.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.